<SEC-DOCUMENT>0001415889-25-021893.txt : 20250814
<SEC-HEADER>0001415889-25-021893.hdr.sgml : 20250814
<ACCEPTANCE-DATETIME>20250814163723
ACCESSION NUMBER:		0001415889-25-021893
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250814
DATE AS OF CHANGE:		20250814

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Autonomix Medical, Inc.
		CENTRAL INDEX KEY:			0001617867
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				471607810
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94449
		FILM NUMBER:		251220178

	BUSINESS ADDRESS:	
		STREET 1:		21 WATERWAY AVENUE, SUITE 300
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77380
		BUSINESS PHONE:		832-277-7816

	MAIL ADDRESS:	
		STREET 1:		21 WATERWAY AVENUE, SUITE 300
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77380

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioStar Ventures III, L.P.
		CENTRAL INDEX KEY:			0001577164
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		206 BRIDGE STREET
		CITY:			CHARLEVOIX
		STATE:			MI
		ZIP:			49720
		BUSINESS PHONE:		(231) 437-7622

	MAIL ADDRESS:	
		STREET 1:		206 BRIDGE STREET
		CITY:			CHARLEVOIX
		STATE:			MI
		ZIP:			49720
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
		<previousAccessionNumber>0001104659-24-106486</previousAccessionNumber>
	    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001577164</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>





    </filerInfo>
  </headerData>

  <formData>
    <coverPageHeader>
		<amendmentNo>1</amendmentNo>
	      <securitiesClassTitle>Common Stock, $0.001 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>06/30/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001617867</issuerCik>        <issuerName>Autonomix Medical, Inc.</issuerName>        <issuerCusip>05330T205</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>21 Waterway Avenue, Suite 300</com:street1>
                    <com:city>The Woodlands</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>77380</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>

	        <designateRulesPursuantThisScheduleFiled>
	           <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
						      </designateRulesPursuantThisScheduleFiled>

    </coverPageHeader>

	    <coverPageHeaderReportingPersonDetails>




    <reportingPersonName>BioStar Ventures III, L.P.</reportingPersonName>

	  		<memberGroup>b</memberGroup>


		 <citizenshipOrOrganization>DE</citizenshipOrOrganization>

      <reportingPersonBeneficiallyOwnedNumberOfShares>
                <soleVotingPower>175216.00</soleVotingPower>
                          <sharedVotingPower>0.00</sharedVotingPower>
                          <soleDispositivePower>175216.00</soleDispositivePower>
                         <sharedDispositivePower>0.00</sharedDispositivePower>
             </reportingPersonBeneficiallyOwnedNumberOfShares>

              <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>175216.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>


     	    <classPercent>4.3</classPercent>





	        <typeOfReportingPerson>PN</typeOfReportingPerson>









    </coverPageHeaderReportingPersonDetails>
	    <coverPageHeaderReportingPersonDetails>



    <reportingPersonName>BioStar Ventures III, L.L.C.</reportingPersonName>

	  		<memberGroup>b</memberGroup>


		 <citizenshipOrOrganization>DE</citizenshipOrOrganization>

      <reportingPersonBeneficiallyOwnedNumberOfShares>
                <soleVotingPower>0.00</soleVotingPower>
                          <sharedVotingPower>175216.00</sharedVotingPower>
                          <soleDispositivePower>0.00</soleDispositivePower>
                         <sharedDispositivePower>175216.00</sharedDispositivePower>
             </reportingPersonBeneficiallyOwnedNumberOfShares>

              <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>175216.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>


     	    <classPercent>4.3</classPercent>











	        <typeOfReportingPerson>OO</typeOfReportingPerson>



    </coverPageHeaderReportingPersonDetails>

    <items>
      <item1>
        <issuerName>Autonomix Medical, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>21 Waterway Avenue, Suite 300, The Woodlands, TX, 77380.</issuerPrincipalExecutiveOfficeAddress>
      </item1>

      <item2>
        <filingPersonName>The names of the persons filing this report (collectively, the "Reporting Persons") are:

BioStar Ventures III, L.P. ("BioStar III")
BioStar Ventures III, L.L.C. ("BioStar III GP")

The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G.
</filingPersonName>        <principalBusinessOfficeOrResidenceAddress>206 Bridge Street,
Charlevoix, MI 49720</principalBusinessOfficeOrResidenceAddress>        <citizenship>BioStar III		Delaware
BioStar III GP		Delaware</citizenship>      </item2>

        <item3>
		        <notApplicableFlag>Y</notApplicableFlag>

      </item3>



    <item4>
    <amountBeneficiallyOwned>Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2025 and is incorporated by reference.

BioStar III directly holds (i) 120,816 shares of common stock and (ii) warrants (the "Warrants") exercisable for up to 54,400 shares of common stock.

BioStar III GP is the general partner of BioStar III and shares voting and dispositive power over the securities held by BioStar III.
</amountBeneficiallyOwned>    <classPercent>Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentage of the common stock of the Issuer beneficially owned by such Reporting Person as of June 30, 2025 and is incorporated by reference. The percentage set forth in row 11 is based upon 4,022,625 shares of common stock outstanding as of June 30, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on August 13, 2025, adjusted in accordance with rules of the SEC to include shares issuable upon exercise of the Warrants. </classPercent>
      <numberOfSharesPersonHas>
        <solePowerOrDirectToVote>Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2025 and is incorporated by reference.</solePowerOrDirectToVote>
        <sharedPowerOrDirectToVote>Row 6 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2025 and is incorporated by reference.</sharedPowerOrDirectToVote>
        <solePowerOrDirectToDispose>Row 7 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2025 and is incorporated by reference.</solePowerOrDirectToDispose>
        <sharedPowerOrDirectToDispose>Row 8 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2025 and is incorporated by reference.</sharedPowerOrDirectToDispose>
      </numberOfSharesPersonHas>
    </item4>


        <item5>

            <notApplicableFlag>N</notApplicableFlag>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>

    </item5>


        <item6>
	  	  <notApplicableFlag>Y</notApplicableFlag>
		        </item6>


        <item7>
	  	  <notApplicableFlag>Y</notApplicableFlag>


    </item7>


          <item8>
                <notApplicableFlag>Y</notApplicableFlag>

              </item8>


            <item9>
                <notApplicableFlag>Y</notApplicableFlag>
                      </item9>


      <item10>
                    <notApplicableFlag>Y</notApplicableFlag>

      </item10>
    </items>

		<exhibitInfo>Exhibit 99.1	Joint Filing Agreement</exhibitInfo>

	    <signatureInformation>
      <reportingPersonName>BioStar Ventures III, L.P.</reportingPersonName>

      <signatureDetails>
        <signature>/s/ Louis Cannon, MD</signature>
        <title>By BioStar Ventures III, L.L.C., its General Partner, By Louis Cannon, MD, Senior Managing Director</title>
        <date>08/14/2025</date>
      </signatureDetails>

    </signatureInformation>
	     <signatureInformation>
      <reportingPersonName>BioStar Ventures III, L.L.C.</reportingPersonName>

      <signatureDetails>
        <signature>/s/ Louis Cannon, MD</signature>
        <title>By Louis Cannon, MD, Senior Managing Director</title>
        <date>08/14/2025</date>
      </signatureDetails>

    </signatureInformation>



  </formData>


    </edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex-99-08142025_080821.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
<!DOCTYPE html PUBLIC "-//IETF//DTD HTML//EN">
<html><head><title>ex-99-08142025_080821.htm</title></head><body style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<p style="margin:0px; padding-left:60px" align="center">EXHIBIT 99.1</p>
<p style="margin:0px" align="center"><br></p>
<p style="margin:0px; padding-left:60px" align="center">JOINT FILING AGREEMENT</p>
<p style="margin:0px" align="center"><br></p>
<p style="margin:0px">The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the common stock of Autonomix Medical, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.</p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:4px">Dated: &nbsp;August 14, 2025</p>
<p style="margin-top:0px; margin-bottom:4px"><br></p>
<p style="margin:0px"><b>BioStar Ventures III, L.P.</b></p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px">BioStar Ventures III, L.L.C.</p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; clear:left; float:left">Its:</p>
<p style="margin:0px; text-indent:-2px">General Partner</p>
<p style="margin:0px; clear:left"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px"><u>/s/ Louis Cannon, MD</u></p>
<p style="margin:0px; text-indent:30px; clear:left">Name: Louis Cannon, MD</p>
<p style="margin:0px; text-indent:30px">Title: Senior Managing Director</p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><b>BioStar Ventures III, L.L.C.</b></p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px"><u>/s/ Louis Cannon, MD</u></p>
<p style="margin:0px; text-indent:30px; clear:left">Name: Louis Cannon, MD</p>
<p style="margin:0px; text-indent:30px">Title: Senior Managing Director</p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
</body></html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
